Categories Earnings, Technology

IBM’s stock rallies after strong quarterly results

Shares of IBM (NYSE: IBM) were up nearly 4% in premarket hours on Wednesday after the company beat revenue and earnings estimates for the fourth quarter of 2019 a day earlier. Analysts had forecast adjusted EPS of $4.69 on revenue of $21.6 billion.

IBM reported total revenue of $21.8 billion for the quarter, up 0.1% from the prior-year period. After adjusting for divestitures and currency, revenues rose 3%.

IBM reports Q4 2019 earnings results

GAAP net income was $3.67 billion, or $4.11 per share, compared to $1.95 billion, or $2.15 per share, in the year-ago quarter. Adjusted EPS was $4.71.

CFO James Kavanaugh said, “In 2019, we continued to invest in the higher-value growth areas of the industry and took bold actions, including several divestitures and a major acquisition, to position our business, which are reflected in our strong gross margin performance.”

During the quarter, total cloud revenue rose 21% to $6.8 billion. Red Hat revenue was up 24%.

Also read: Johnson & Johnson Q4 2019 Earnings Report

Cloud & Cognitive Software segment revenues were $7.2 billion, up 8.7%. Global Business Services revenues fell 0.6% to $4.2 billion. Global Technology Services revenues totaled $6.9 billion, down 4.8%. Systems revenues were $3 billion, up 16%. Global Financing revenues of $301 million were down 25.3%.

For the full year of 2020, IBM expects GAAP EPS of at least $10.57, and adjusted EPS of at least $13.35.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top